Glaxosmithkline Pharmaceuticals informs about analyst meet

21 Feb 2024 Evaluate
Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, it enclosed the transcript of the Analyst / Institutional Meeting held on 15th February 2024. The said transcript is also uploaded on the website of the Corporation and can be accessed through the link: https://india-pharma.gsk.com/en-in/investors/analyst-meets/.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2380.90 3.25 (0.14%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×